(lp0
S'Can Pluristem Therapeutics Corner The Acute Radiation Syndrome Market? Seeking Alpha - Apr 11, 2017 For those that like stocks on-the-go, Pluristem Therapeutics  has a pipeline that is already churning out statistically significant results and is well on its way to becoming a richly valued, premium stock.'
p1
aS'Onconova Therapeutics and Pluristem Therapeutics Surge as Candidate Drugs Move ... Yahoo Finance - Apr 5, 2017 Pluristem Therapeutics advanced 8.89% to close at $1.47 a share on Tuesday. The stock traded between $1.36 and $1.54 on volume of 1,700,886 shares traded.'
p2
aS'Pluristem Therapeutics - A Potential Beneficiary Of The 21st Century Cures Act Seeking Alpha - Dec 16, 2016 An accelerated development time frame is obviously huge news for a company like Pluristem since it greatly reduces the amount of cash burn required  and provides a leg-up on competition.'
p3
aS"Pluristem Signs Term Sheet for $30 Million Equity Investment Agreement with a ... GlobeNewswire  - Oct 25, 2016 HAIFA, Israel, Oct. 25, 2016  -- Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapy products, today announced it has signed a term sheet for an investment of approximately&nbsp;...Israel's Pluristem to get $30m Chinese investment - The Times of Israel"
p4
aS'FBR Capital Analyst Bullish on Pluristem Therapeutics Inc.  Following ... Smarter Analyst - Jul 11, 2016 FBR Capital analyst Vernon Bernardino weighed in on Pluristem Therapeutics Inc.  following the an announcement that the company plans to initiate a Phase I trial to investigate its PLX-R18 drug.'
p5
aS'Shares Worth Watching: Pluristem Therapeutics, Inc.  Rockville Register - 19 hours ago In the last session of trading, Pluristem Therapeutics, Inc.  shares changed +1.37%. Sell-side analysts covering the company are looking for the stock to go to $3.25 within the next 52 weeks.'
p6
aS"Pluristem Announces Closing of Bought Offering and Underwriter's Exercise in ... GlobeNewswire  - Jan 25, 2017 HAIFA, Israel, Jan. 25, 2017  -- Pluristem Therapeutics Inc.   announced today that H.C."
p7
aS'Pluristem Announces Bought Deal Offering GlobeNewswire  - Jan 19, 2017 HAIFA, Israel, Jan. 19, 2017  -- Pluristem Therapeutics Inc.   announced today that it has entered into an underwriting agreement with H.C.Pluristem Therapeutics  Increases Bought Deal Offering of Common Stock ... - StreetInsider.com'
p8
aS'Analysts Anticipate Pluristem Therapeutics Inc.  to Announce -$0.07 ... Markets Daily - 15 hours ago Pluristem Therapeutics logo Wall Street brokerages expect Pluristem Therapeutics Inc.  to announce earnings of  per share for the current quarter, Zacks Investment Research reports.The Pluristem Therapeutics Inc.  Lowered to Hold at Zacks Investment ... - Petro Global News 24Pluristem Therapeutics, Inc.  Reviewed By Analysts - The De Soto Edge'
p9
aS'Pluristem Therapeutics  Shares March Higher, Can It Continue? Nasdaq - Apr 6, 2017 As of late, it has definitely been a great time to be an investor in Pluristem Therapeutics Inc. PSTI . The stock has moved higher by 25.6% in the past month, while it is also above its 20 Day SMA too.'
p10
a.